Clinical significance of p53, mdm2, and bcl-2 proteins in renal cell carcinoma

By Uchida T.   Gao J.-P.   Wang C.   Jiang S.-X.   Muramoto M.   Satoh T.   Minei S.   Shimura S.   Irie A.   Kameya T.   Baba S.  

Urology, Vol. 59, Iss. 4, 2002-04 ,pp. : 615-620

Elsevier

Access to resources Recommend Favorite

p53, bcl-2, and Bax Expression in Renal Cell Carcinoma - immunohistochemical detection of p53 protein versus clinicopathologic parameters

By Vasavada S.P.   Novick A.C.   Williams B.R.G.  

Urology, Vol. 51, Iss. 6, 1998-06 ,pp. : 1057-1061

Elsevier

Access to resources Recommend Favorite

p53 Expression in Correlation to Clinical Outcome in Patients with Renal Cell Carcinoma

By Ljungberg B.   Bozoky B.   Kovacs G.   Stattin P.   Farrelly E.   Nylander K.   Landberg G.  

Scandinavian Journal of Urology and Nephrology, Vol. 35, Iss. 1, 2001-01 ,pp. : 15-20

Informa Healthcare

Access to resources Recommend Favorite

Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma

By Rioux-Leclercq N.   Turlin B.   Bansard J.-Y.   Patard J.-J.   Manunta A.   Moulinoux J.-P.   Guille F.   Ramee M.-P.   Lobel B.  

Urology, Vol. 55, Iss. 4, 2000-04 ,pp. : 501-505

Elsevier

Access to resources Recommend Favorite

The significance of p53 and bcl-2 overexpression and other prognostic factors in transitional cell carcinoma of the bladder

By Touloupidis Stavros   Fatles Georgios   Kalaitzis Christos   Giatromanolaki Alexandra   Sivridis Eythimyos   Simopoulos Konstantinos   Rombis Vassilios  

International Urology and Nephrology, Vol. 38, Iss. 2, 2006-06 ,pp. : 231-236

Springer Publishing Company

Access to resources Recommend Favorite